Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Phosphatidylserine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Phosphatidylserine market segmented into
Dietary Supplement
50% Content
Other Content
Based on the end-use, the global Phosphatidylserine market classified into
Dietary Supplement
Functional Foods
Medical Foods
Others
Based on geography, the global Phosphatidylserine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Chemi Nutra
Lipoid
Lipogen
Novastell
Lonza
Glonet (Doosan Group)
Enzymtec Sharp.PS
BHN
Sino Herb
H&C pharmaceutical (CSHPHARM)
Guanjie Biotech
L&P Food Ingredient
Baianrui Biotech
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PHOSPHATIDYLSERINE INDUSTRY
2.1 Summary about Phosphatidylserine Industry
2.2 Phosphatidylserine Market Trends
2.2.1 Phosphatidylserine Production & Consumption Trends
2.2.2 Phosphatidylserine Demand Structure Trends
2.3 Phosphatidylserine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 20% Content
4.2.2 50% Content
4.2.3 Other Content
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Dietary Supplement
4.3.2 Functional Foods
4.3.3 Medical Foods
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 20% Content
5.2.2 50% Content
5.2.3 Other Content
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Dietary Supplement
5.3.2 Functional Foods
5.3.3 Medical Foods
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 20% Content
6.2.2 50% Content
6.2.3 Other Content
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Dietary Supplement
6.3.2 Functional Foods
6.3.3 Medical Foods
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 20% Content
7.2.2 50% Content
7.2.3 Other Content
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Dietary Supplement
7.3.2 Functional Foods
7.3.3 Medical Foods
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 20% Content
8.2.2 50% Content
8.2.3 Other Content
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Dietary Supplement
8.3.2 Functional Foods
8.3.3 Medical Foods
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 20% Content
9.2.2 50% Content
9.2.3 Other Content
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Dietary Supplement
9.3.2 Functional Foods
9.3.3 Medical Foods
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Chemi Nutra
10.1.2 Lipoid
10.1.3 Lipogen
10.1.4 Novastell
10.1.5 Lonza
10.1.6 Glonet (Doosan Group)
10.1.7 Enzymtec Sharp.PS
10.1.8 BHN
10.1.9 Sino Herb
10.1.10 H&C pharmaceutical (CSHPHARM)
10.1.11 Guanjie Biotech
10.1.12 L&P Food Ingredient
10.1.13 Baianrui Biotech
10.2 Phosphatidylserine Sales Date of Major Players (2017-2020e)
10.2.1 Chemi Nutra
10.2.2 Lipoid
10.2.3 Lipogen
10.2.4 Novastell
10.2.5 Lonza
10.2.6 Glonet (Doosan Group)
10.2.7 Enzymtec Sharp.PS
10.2.8 BHN
10.2.9 Sino Herb
10.2.10 H&C pharmaceutical (CSHPHARM)
10.2.11 Guanjie Biotech
10.2.12 L&P Food Ingredient
10.2.13 Baianrui Biotech
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT